BM-613

CCCCCNC(=O)NS(=O)(=O)C1=CC(=CC=C1NC2=CC=C(C)C=C2)[N+]([O-])=O

InChIKey=ZXEYXJKZEQUHBP-UHFFFAOYSA-N

InChI=1S/C19H24N4O5S/c1-3-4-5-12-20-19(24)22-29(27,28)18-13-16(23(25)26)10-11-17(18)21-15-8-6-14(2)7-9-15/h6-11,13,21H,3-5,12H2,1-2H3,(H2,20,22,24)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.	2005-04	15626721

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:38:30 GMT 2025` Edited by `admin` on `Mon Mar 31 23:38:30 GMT 2025`
Record UNII	PB9LJH9R4Y
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

BM-613

Common Name

English

BENZENESULFONAMIDE, 2-((4-METHYLPHENYL)AMINO)-5-NITRO-N-((PENTYLAMINO)CARBONYL)-

Preferred Name

English

Code System Code Type Description

CAS

284465-11-8

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

PUBCHEM

11676121

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

FDA UNII

PB9LJH9R4Y

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

Related Record Type Details


					PB9LJH9R4Y

BM-613

ACTIVE MOIETY